“…One of the most promising approaches to overcome these issues is to encapsulate AMPs into functional carrier systems that can protect them from degradation, tailor their release profile, and target their delivery. − Dispersions of inverted-type nonlamellar liquid crystalline structures and micelles raised considerable attention in this direction due to their large water–lipid interfacial area with the ability to solubilize hydrophobic, hydrophilic, and amphiphilic molecules. − Such solution-based nanocarriers based on amphiphilic lipids including glycerol monooleate (GMO) and oleic acid (OA) were recently designed for the delivery of AMPs. − ,− These lipid/AMP self-assemblies were discovered to even modify the antibacterial activity of the human cathelicidin-derived AMP LL-37, depending on their nanostructure. ,, pH-switchable antibacterial nanoparticles could be designed based on the pH-responsive self-assembly of the LL-37/OA system . However, to the best of our knowledge, the design of antimicrobial coatings based on AMP-loaded nonlamellar liquid crystalline structures has not yet been reported.…”